A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by S-1 and gemcitabine combination chemotherapy

Japanese Journal of Cancer and Chemotherapy

Volumn 36, Issue 12, 2009, Pages 2419-2421

  Hoshino, Hiromitsu ^a   Takeda, Yutaka ^a   Nagano, Hiroaki ^a   Nakamori, Shoji ^b   Kobayashi, Shogo ^a   Eguchi, Hidetoshi ^a   Marubashi, Shigeru ^a   Tanemura, Masahiro ^a   Kitagawa, Toru ^a   Umeshita, Koji ^a   Monden, Morito ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Chemotherapy; Gemcitabine; S 1

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; GEMCITABINE;

ADENOCARCINOMA; CHEMORADIOTHERAPY; CHEMOTHERAPY; COMBINATION CHEMOTHERAPY; EXAMINATION; FEMALE; HEAD CANCER; HUMAN; IMAGING; LIVER METASTASIS; LONG TERM SURVIVAL; LYMPH NODE DISSECTION; METASTASIS; MONOTHERAPY; PANCREAS; PANCREAS CANCER; PANCREATICODUODENECTOMY; PATIENT; SERUM; SURGERY; THERAPY;

EID: 84864598698     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Burris HA 3rd, Moore MJ, Andersen J, et al: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413.1997.
2. Sultana A, Smith CT, Cunningham D, et al: Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol 25:2607-2615.2007.
3. Nakamura K, Yamaguchi T. Ishihara T, et al: Phase II trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer. Br J Cancer, 94:1575-1579. 2006.
4. Yamauchi J, Kanai M, Matsumoto S, et al: Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer. Pancreas 36:327-328. 2008.
5. Lee GW, Kim HJ. Ju JH. et al: Phase II trial" of S-1 in combination with gemcitabine for chemo-naive patients with locally advanced or metastatic pancreatic cancer. Cancer Chemother Pharmacol 64:707-713, 2009.
6. Nakahira S, Nakamori S, Tsujie M, et al: Pretreatment with S-1, an oral derivative of 5-fluorouracil, enhances gemcitabine effects in pancreatic cancer xenografts. Anticancer Res 28:179-186. 2008.